IPP Bureau
KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
By IPP Bureau - May 19, 2023
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
By IPP Bureau - May 19, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Philips’ image-guided navigation increases safety during coronary interventions
By IPP Bureau - May 17, 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr
By IPP Bureau - May 17, 2023
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
Envision Scientific receives IGBC Gold Certification for India factory
By IPP Bureau - May 17, 2023
Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose
By IPP Bureau - May 17, 2023
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData
By IPP Bureau - May 17, 2023
Farxiga is expected to have such a strong influence on the market due to the impressive results
Hikal announces USFDA audit with zero observations
By IPP Bureau - May 16, 2023
This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites
AiMeD welcomes Govt’s for assistance to medical devices clusters
By IPP Bureau - May 16, 2023
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
Health Minister Mandaviya invites Japanese pharma companies to invest in India
By IPP Bureau - May 16, 2023
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Mandaviya addresses the G7 Health Ministerial Meeting on health innovation
By IPP Bureau - May 16, 2023
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Mandaviya addresses the G7 Ministerial Meeting on global health architecture
By IPP Bureau - May 16, 2023
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
Kraiburg TPE is breaking the mold in Asia Pacific’s innovative medical devices
By IPP Bureau - May 15, 2023
To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series
Medico Remedies to foray into ointment manufacturing segment
By IPP Bureau - May 15, 2023
The facility will have a capacity to manufacture upto 3 million tubes monthly
Advanced Enzyme Technologies posts Q4 FY23 consolidated PAT up at Rs. 32.12 Cr
By IPP Bureau - May 15, 2023
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
